<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00471523</url>
  </required_header>
  <id_info>
    <org_study_id>02-2006</org_study_id>
    <nct_id>NCT00471523</nct_id>
  </id_info>
  <brief_title>Treatment of Anovulatory Infertility in PCOS Patients</brief_title>
  <official_title>Clomiphene Citrate Versus Metformin as First-Line Approach for the Treatment of Anovulation in Infertile Patients With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Magna Graecia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Magna Graecia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clomiphene citrate (CC) and metformin are two effective drugs used to induce ovulation in
      patients with polycystic ovary syndrome (PCOS), even if it is still unclear which compound
      between them should be initially administered. The aim of the study will be to compare in a
      clinical setting the efficacy of CC and metformin as first-line approaches for treating
      anovulation in infertile PCOS patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eighty infertile anovulatory patients with PCOS will be allocated in two body mass index
      (BMI)- and age-matched groups (experimental and control groups).

      Forty patients will receive the experimental treatment consisting of six months of 1700
      mg/day metformin administration (experimental group), whereas other forty patients will
      receive CC administered using a traditional incremental-doses protocol (control group). In
      both groups, patients who will ovulate under treatment will continue the therapy for a total
      of six months.

      During the study, the clinical and reproductive outcomes, and the adverse experience will be
      evaluated in each patient.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>10 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ovulation rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abortion rate</measure>
    <time_frame>10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first pregnancy</measure>
    <time_frame>10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>N. pregnancies/n. ovulatory cycles</measure>
    <time_frame>10 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">80</enrollment>
  <condition>Infertility</condition>
  <condition>Polycystic Ovary Syndrome</condition>
  <condition>Anovulation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene citrate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Anovulatory infertility related to polycystic ovary syndrome

        Exclusion Criteria:

          -  Neoplastic, metabolic, hepatic, and cardiovascular disorders or other concurrent
             medical illnesses

          -  Hypothyroidism, hyperprolactinemia, Cushing’s syndrome, and non-classical congenital
             adrenal hyperplasia

          -  Current or previous (within the last six months) use of oral contraceptives,
             glucocorticoids, antiandrogens, ovulation induction agents, antidiabetic and
             anti-obesity drugs or other hormonal drugs.

          -  Organic pelvic diseases

          -  Previous pelvic surgery

          -  Suspected peritoneal factor infertility

          -  Tubal or male factor infertility or sub-fertility
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Palomba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics &amp; Gynecology, University “Magna Graecia” of Catanzaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Achille Tolino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics &amp; Gynecology, University “Federico II” of Naples</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Orio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Endocrinology, University “Federico II” of Naples</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>&quot;Pugliese Hospital&quot;</name>
      <address>
        <city>Catanzaro</city>
        <state>CZ</state>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T, Tolino A, Carmina E, Colao A, Zullo F. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005 Jul;90(7):4068-74. Epub 2005 Apr 19.</citation>
    <PMID>15840746</PMID>
  </reference>
  <reference>
    <citation>Palomba S, Orio F Jr, Falbo A, Russo T, Tolino A, Zullo F. Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome. Fertil Steril. 2006 Dec;86(6):1694-701. Epub 2006 Oct 30.</citation>
    <PMID>17074337</PMID>
  </reference>
  <reference>
    <citation>Palomba S, Orio F, Zullo F. Ovulation induction in women with polycystic ovary syndrome. Fertil Steril. 2006 Jul;86 Suppl 1:S26-7.</citation>
    <PMID>16798282</PMID>
  </reference>
  <reference>
    <citation>Palomba S, Russo T, Orio F Jr, Falbo A, Manguso F, Sammartino A, Tolino A, Colao A, Carmina E, Zullo F. Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study. Hum Reprod. 2006 Nov;21(11):2823-9. Epub 2006 Jul 10.</citation>
    <PMID>16835214</PMID>
  </reference>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2007</study_first_submitted>
  <study_first_submitted_qc>May 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2007</study_first_posted>
  <last_update_submitted>May 8, 2007</last_update_submitted>
  <last_update_submitted_qc>May 8, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2007</last_update_posted>
  <keyword>Anovulation</keyword>
  <keyword>Clomiphene citrate</keyword>
  <keyword>Infertility</keyword>
  <keyword>Metformin</keyword>
  <keyword>PCOS</keyword>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Anovulation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

